Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.58
Delayed Data
As of 10:11am ET
 +0.06 / +3.95%
Today’s Change
1.30
Today|||52-Week Range
5.12
-16.84%
Year-to-Date

Today’s Trading

Previous close1.52
Today’s open1.52
Day’s range1.52 - 1.59
Volume236,323
Average volume (3 months)3,026,992
Market cap$368.7M
Dividend yield--
Data as of 10:11am ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-211.11%
Earnings growth (this year)-61.22%
Earnings growth (next 5 years)-45.30%
Revenue growth (last year)-54.58%
P/E ratioNM
Price/Sales20.62
Price/Book7.07

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.01+0.15%
OTICOtonomy Inc+0.51+3.99%
FLMLFlamel Technologies ...+0.23+2.49%
MRTXMirati Therapeutics ...+1.46+7.75%
Data as of 10:26am ET, 02/10/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$37.0M
Annual profit (last year)-$60.5M
Net profit margin-163.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harry F. Hixson
SVP-Operations &
Head-Global Regulatory Affairs
Craig M. Audet
Corporate headquarters
San Diego, California

Forecasts

Partner Offers